mortality/aging
• occurs at 59 +/- 19 days due to cachexia and respiratory insufficiency
(J:81791)
(J:179741)
|
• hemizygous males are underrepresented ( 16.6% instead of the expected 25%) suggesting a certain degree of pre- or neonatal lethality, however no time of death was reported
|
growth/size/body
• a progressive growth impairment compared to wild-type littermates reaching a 35% reduction of body weight by 57 days
|
behavior/neurological
• a progressive motor deficit
|
• a decreased muscular strength starting in the hindlimbs at 4-5 weeks
|
• hindlimbs become completely paralyzed by 8 weeks
|
muscle
• altered emplacement of mitochondria
• myofibrillar disorganization with sarcomeric disarray and Z-ine streaming that may originated from ER dilations
• atrophy and loss of myofibrils
• frequently seen vacuoles do not contain cellular debris as observed in autophagic vacuoles
|
• a progressive amyotrophy
|
• presence of an abnormal central, peripheral, or anarchical pattern of oxidative enzyme activity in myofibers
|
(J:81791)
(J:179741)
|
• skeletal muscle demonstrated a generalized myopathy with fiber size variation, hypotrophy, and progressive accumulation of paracentral or central nuclei
• myogenesis is not delayed
• inflammatory infiltrates and fibrosis, generally present in dystrophic muscle, were absent
• neither necrotic nor apoptotic muscle fibers were seen
|
skeleton
respiratory system
• by 8 weeks
|
limbs/digits/tail
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
centronuclear myopathy | DOID:14717 | J:81791 |